Healthcare / Medical DevicesNasdaqGM
$0.91
+0.00 (+0.00%)
FCF base 3Y
n/d
n/d CAGR · yield n/d
FCF base 5Y
n/d
n/d base · n/d expected
Precio de entrada
n/d
MOS 33% · confianza 24%
FCF escenarios
weak_data · normalized FCF $-97.2M · quality 55.0/100
Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.
SA Score
2/100
F
Piotroski
2/9
balance/quality
Valuation
50/100
+0.0% upside
5Y CAGR
+0.0%
50/100
Data QA
20/100
SEC 0%
Sin guardar todavía.
Market Cap
$197M
P/E
N/A
•EV/EBITDA
N/A
•ROE
-46.0%
↓Gross Margin
47.3%
↓Debt/Equity
N/A
•Absolute Values (Left Axis)
Ratios / Percentages (Right Axis)
Financial statement dashboard
2019–2025 · 6 años de histórico normalizado
Revenue CAGR
—
FCF CAGR
—
FCF margin
-3991.5%
FCF / Net income
0.96x
Latest source
Provider fallback
Margin decomposition
Último año: revenue $2.4M · net income $-101.3M · FCF $-97.2M
Gross margin
Operating margin
Net margin
FCF margin
| Metric | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||
| Revenue | $2.4M | $2.4M | $3.1M | $1.1M | $0.00 | $0.00 | — | — |
| Net Income | $-101.3M | $-101.3M | $-101.0M | $-96.0M | $-132.4M | $-95.0M | $-36.6M | $-35.8M |
| EBITDA | $-111.6M | $-111.6M | $-104.0M | $-107.0M | $-121.3M | $-95.9M | $-35.8M | $-35.8M |
| EPS | -0.51 | -0.51 | -0.71 | -0.68 | -0.95 | -1.19 | -6.84 | -6.95 |
| Gross Margin | 47.3% | 47.3% | 52.3% | 45.1% | — | — | — | — |
| Operating Margin | -4766.0% | -4766.0% | -3550.6% | -10274.6% | — | — | — | — |
| Net Margin | -4160.1% | -4160.1% | -3303.0% | -8868.8% | — | — | — | — |
| Cash Flow | ||||||||
| Free Cash Flow | $-97.2M | $-97.2M | $-92.4M | $-98.5M | $-101.3M | $-72.6M | $-33.0M | $-31.9M |
| Returns | ||||||||
| ROE | -46.0% | -46.0% | -46.9% | -35.3% | -36.9% | -19.9% | 22.9% | 28.6% |
| Growth & Yield | ||||||||
| Revenue Growth | -20.3% | -20.3% | 182.6% | — | — | — | — | — |
| EPS Growth | 28.2% | 28.2% | -4.4% | 28.4% | 20.2% | 82.6% | 1.6% | — |
Revenue, Net Income & Free Cash Flow ($B)
Margins (%)
Returns (%)
Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.
Unavailable: positive start/end prices are required.